Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Recurrence 1Peritoneal Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Immunologic Deficiency Syndromes 1Glioblastoma 1Genital Neoplasms, Female 1Fallopian Tube Neoplasms 1Epstein-Barr Virus Infections 1Cytomegalovirus Infections 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma in Situ 1Adenoviridae Infections 1Abdominal Neoplasms 1

Interventions

Valganciclovir 3Rituximab 3Cisplatin 3Vincristine 2Radiotherapy, Intensity-Modulated 2Prednisone 2Matrix-M 2Gemcitabine 2Etoposide 2Doxorubicin 2Cyclophosphamide 2pomalidomide 1dehydroftorafur 1brincidofovir 1Watchful Waiting 1Valacyclovir 1Tomography, X-Ray Computed 1Tenofovir 1Tegafur 1Taxes 1Platinum 1Phantoms, Imaging 1Paclitaxel 1Nivolumab 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Mitomycin 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Interferons 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Epstein-Barr Virus Infections × Cell Count × 1 year × Clear all
NCT06926894 2025-07-31

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Columbia University

Phase 1 Recruiting
18 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Immunologic Deficiency Syndromes, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡